Cholesterol-lowering effect of platycodin D in hypercholesterolemic ICR mice

European Journal of Pharmacology

Volumn 537, Issue 1-3, 2006, Pages 166-173

  Zhao, Hai Lin ^a   Cho, Kyung Hyun ^b   Ha, Young Wan ^a   Jeong, Tae Sook ^c   Lee, Woo Song ^c   Kim, Yeong Shik ^a  

^a Seoul National University   (South Korea)

^b Yeungnam University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

ACAT inhibition; Anti obesity; Cholesterol lowering; Farnesoid X receptor; Platycodin D

Indexed keywords

CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; FARNESOID X RECEPTOR; HYPOCHOLESTEROLEMIC AGENT; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A2; PLATYCODIN; PLATYCODON GRANDIFLORUM EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SCREENING; ENZYME INHIBITION; FECES ANALYSIS; FOOD INTAKE; HYPERCHOLESTEROLEMIA; HYPOCHOLESTEROLEMIA; IN VITRO STUDY; IN VIVO STUDY; LIPID LIVER LEVEL; LIVER; MALE; MOUSE; NONHUMAN; OXIDATION; PLANT ROOT; PLATYCODON; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; EATING; FECES; HYPERCHOLESTEROLEMIA; LIVER; MALE; MICE; MICE, INBRED ICR; SAPONINS; TRIGLYCERIDES; TRITERPENES; WEIGHT GAIN;

EID: 33646127601     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.032     Document Type: Article

References (29)

1. Accad M., Smith S.J., Newland D.L., Sanan D.A., King Jr. L.E., Linton M.F., Fazio S., and Farese Jr. R.V. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J. Clin. Invest. 105 (2000) 711-719
2. Ahn K.S., Noh E.J., Zhao H.L., Jung S.H., Kang S.S., and Kim Y.S. Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-kB activation in RAW 264.7 cells. Life Sciences 76 (2005) 2315-2328
3. Bramlett K.S., Yao S., and Burris T.P. Correlation of Farnesoid X receptor coactivator recruitment and cholesterol 7 a-hydroxylase gene repression by bile acids. Mol. Genet. Metab. 71 (2000) 609-615
4. Bramlett K.S., Houck K.A., Borchert K.M., Dowless M.S., Kulanthaivel P., Zhang Y., Beyer T.P., Schmidt R., Thomas J.S., Michael L.F., Barr R., Montrose C., Eacho P.I., Cao G., and Burris T.P. A natural product ligand of the oxysterol receptor, liver X receptor. J. Pharmacol. Exp. Ther. 307 (2003) 291-296
5. Chang C.C., Sakashita N., Ornvold K., Lee O., Chang E.T., Dong R., Lin S., Lee C.Y., Strom S.C., Kashyap R., Fung J.J., Farese Jr. R.V., Patoiseau J.F., Delhon A., and Chang T.Y. Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J. Biol. Chem. 275 (2000) 28083-28092
6. Cho K.H., An S., Lee W.S., Paik Y.K., Kim Y.K., and Jeong T.S. Mass-production of human ACAT-1 and ACAT-2 to screen isoform-specific inhibitor: a different substrate specificity and inhibitory regulation. Biochem. Biophys. Res. Commun. 309 (2003) 864-872
7. Cho K.H., Park J., Han J., and Jeong T.S. Ligand binding domain of farnesoid X receptor revealed the best sensitivity and activity among FXR variants from fluorescence-based assay. Lipids 38 (2003) 1149-1156
8. Choi C.Y., Kim J.Y., Kim Y.S., Chung Y.C., Hahm K.S., and Jeong H.G. Augmentation of macrophage functions by an aqueous extract isolated from Platycodon grandiflorum. Cancer Lett. 166 (2001) 17-25
9. Choi C.Y., Kim J.Y., Kim Y.S., Chung Y.C., Seo J.K., and Jeong H.G. Aqueous extract isolated from Platycodon grandiflorum elicits the release of nitric oxide and tumor necrosis factor-alpha from murine macrophages. Int. Immunopharmacol. 1 (2001) 1141-1151
10. Davis R.A., Miyake J.H., Hui T.Y., and Spann N.J. Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP. J. Lipid Res. 43 (2002) 533-543
11. Folch J., Ascoli I., Lees M., Meath J.A., and Le B.N. Preparation of lipide extracts from brain tissue. J. Biol. Chem. 191 (1951) 833-841
12. 2, platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2909-2917
13. Han L.K., Xu B.J., Kimura Y., Zheng Y., and Okuda H. Platycodi Radix affects lipid metabolism in mice with high fat diet-induced obesity. J. Nutr. 130 (2000) 2760-2764
14. Han L.K., Zheng Y.N., Xu B.J., Okuda H., and Kimura Y. Saponins from Platycodi Radix ameliorate high fat diet-induced obesity in mice. J. Nutr. 132 (2002) 2241-2245
15. Harris W.S., Dujovne C.A., Windsor S.L., Gerrond L.L., Newton F.A., and Gelfand R.A. Inhibiting cholesterol absorption with CP-88,818 (beta-tigogenin cellobioside; tiqueside): studies in normal and hyperlipidemic subjects. J. Cardiovasc. Pharmacol. 30 (1997) 55-60
16. Harwood H.J., Chandler C.E., Pellarin L.D., Bangerter F.W., Wilkins R.W., Long C.A., Cosgrove P.G., Malinow M.R., Marzetta C.A., Pettini J.L., et al. Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin beta-tigogenin cellobioside (CP-88818; tiqueside). J. Lipid Res. 34 (1993) 377-395
17. Havel R.J., Eder H.A., and Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34 (1955) 1345-1353
18. Heck A.M., Yanovski J.A., and Calis K.A. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 20 (2000) 270-279
19. Ishii H., Tori K., and Yoshimura Y. Saponins from the roots of Platycodon grandiflorum. Part 1. Structure of prosapogenins. J. Chem. Soc., Perkin Trans., 1 1 (1981) 1928-1933
20. Ishii H., Tori K., Tozyo T., and Yoshimura Y. Saponins from roots of Platycodon grandiflorum. Part 2. Isolation and structure of new triterpene glycosides. J. Chem. Soc., Perkin Trans., 1 1 (1984) 661-668
21. Kanda T., Foucand L., Nakamura Y., Niot I., Besnard P., Fujita M., Sakai Y., Hatakeyama K., Ono T., and Fujii H. Regulation of expression of human intestinal bile acid-binding protein in Caco-2 cells. Biochem. J. 330 Pt. 1 (1998) 261-265
22. 2 production by platycodin D isolated from the root of Platycodon grandiflorum. Planta Med. 67 (2001) 362-364
23. 2: a potential new risk factor for coronary artery disease and a therapeutic target. Curr. Opin. Pharmacol. 1 (2001) 121-125
24. Morehouse L.A., Bangerter F.W., DeNinno M.P., Inskeep P.B., McCarthy P.A., Pettini J.L., Savoy Y.E., Sugarman E.D., Wilkins R.W., Wilson T.C., Woody H.A., Zaccaro L.M., and Chandler C.E. Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: evidence for a non-stoichiometric, intestinal mechanism of action. J. Lipid Res. 40 (1999) 464-474
25. Oakenfull D.G., and Topping D.L. Saponins and plasma cholesterol. Atherosclerosis 48 (1983) 301-303
26. Uusitupa M. New aspects in the management of obesity: operation and the impact of lipase inhibitors. Curr. Opin. Lipidol. 10 (1999) 3-7
27. Vlahcevic Z.R., Gurley E.C., Heuman D.M., and Hylemon P.B. Bile salts in submicellar concentrations promote bidirectional cholesterol transfer (exchange) as a function of their hydrophobicity. J. Lipid Res. 31 6 (1990) 1063-1071
28. Yancey P.G., and Jerome W.G. Lysosomal sequestration of free and esterified cholesterol from oxidized low density lipoprotein in macrophages of different species. J. Lipid Res. 39 (1998) 1349-1361
29. Zhao H.L., Sim J.-S., Shim S.H., Ha Y.W., Kang S.S., and Kim Y.S. Anti-obese and hypolipidemic effects of platycodin saponins in diet-induced obese rats: evidences for lipase inhibition and calorie intake restriction. Int. J. Obes. 29 (2005) 983-990